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ypertension remains a major contributing factor for cardiovas-
ular and cerebrovascular diseases. Optimal blood pressure (BP)
ontrol is therefore of great importance. Several nonpharmacologi-
al interventions exist to optimize BP, including the reduction of
lcohol intake, weight loss, and limiting dietary sodium to 100
mol/day (1). Notably, many clinical studies also support the
P-lowering effects of potassium supplementation (2–8).
In 1 placebo-controlled study of 104 hypertensive patients, a
elatively low dose of potassium aspartate (30 mmol/day) led to
tatistically significant sustained reductions in office and 24-h
mbulatory systolic and diastolic BPs (p  0.001) (2). Significant
eductions (p 0.001) in both home (3.6 0.9 mmHg/1.7 0.5
m Hg) and 24-h systolic BP (3.4  1.0 mm Hg/1.2  0.5 mm
g) was also observed in another randomized study of 55 patients
ith essential hypertension who were treated with potassium
hloride supplementation (64 mmol/day) for 4 weeks compared
ith placebo (8). Participants in a larger randomized, double-
lind, placebo-controlled trial (n  150) given potassium chloride
60 mmol/day) for 12 weeks also experienced significant reductions
n systolic BP (–5.0 mm Hg, 95% confidence interval: –2.1 to –7.9
m Hg, p  0.001) (6).
Finally, a pooled meta-analysis of 33 randomized controlled
rials on the effects of potassium chloride supplementation (average
f 75 mmol/day) on BP in hypertensive and normotensive patients
emonstrated a significant reduction in average BP of 3.1/2.0 mm
g with potassium (3). The BP-lowering effects of potassium
ended to be greater in hypertensive patients (4.4/2.5 mm Hg)
han in normotensive patients (1.8/1.0 mm Hg) (3). The authors
f that study concluded that “increased potassium intake should be
onsidered as a recommendation for prevention and treatment of
ypertension.”
Therefore, maintenance of adequate dietary potassium intake
hows promise in the prevention and treatment of hypertension
nd should be thought of as part of the armamentarium of lifestyle
hanges.
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1) and are well aware of information that potassium supplemen-
ation ameliorates hypertension. In fact, this concept is well known
nd was described more than a quarter century ago (2,3). In most
uman studies, patients who were evaluated did not have resistant
ypertension as defined by the current definition. In most clinical
tudies, potassium supplementation, although reducing blood
ressure (BP), provides an average reduction of only 3 to 6 mmHg
n systolic pressure. Although this reduction is meaningful, such a
eduction in BP would not be sufficient to supplant antihyperten-
ive medications in resistant hypertensive patients. Moreover, we
o specifically mention the importance of potassium levels when
onsidering BP treatment, but because most patients with resistant
ypertension have chronic kidney disease, hypokalemia is generally
ot as common a problem as hyperkalemia.
Finally, we had a case referral that was presented at the
merican Heart Association in 2007 for resistant hypertension.
he was taking 3 full-dose antihypertensive medications with
erum potassium of 3.2 mEq/l and was consuming a daily diet that
ontained 35 g of sodium, based on a 24-h urine result. After
lacing her on a 3-g sodium diet and administering amiloride and
hort-term potassium supplementation (i.e., 2 weeks) along with
ncreasing her fruit and vegetable intake for 1 month, we were able
o stop all of her antihypertensive medications. At this time, her
erum potassium was corrected to 4.1 mEq/l, and her daily sodium
ntake was 2.8 g/day. Her blood pressure was reduced from 144/86
m Hg on triple therapy to 128/82 mm Hg on no medications
nd a high-potassium, low-sodium diet. The lesson of this case is
ot just that potassium intake is important but that the balance of
odium, potassium, and probably magnesium are important for
aintaining arterial homeostasis (4).
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